NCT05969717 - Induced Pluripotent Stem Cell Derived Exosomes for the Treatment of Atopic Dermatitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 12, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

June 30, 2025

Conditions

Atopic Dermatitis

Interventions

DRUG

GD-iExo-001

One drop (about 50 μL) of GD-iExo-001 was given to the affected skin area of 2-4 cm2 for 14 consecutive days, twice per day.

OTHER

normal saline

One drop (about 50 μL) of normal saline was given to the affected skin area of 2-4 cm2 for 14 consecutive days, twice per day.

Trial Locations (1)

RECRUITING

Chinese Academy of Medical Science & Peking Union Medical College Hospital, Beijing